Evidence map›Paper›PMID 31510681›Full record

ArticleBioinformatics (Oxford, England)2019

Alignment-free filtering for cfNA fusion fragments.

Xiao Yang, Yasushi Saito, Arjun Rao, Hyunsung John Kim, Pranav Singh, Eric Scott, Matthew Larson, Wenying Pan, Mohini Desai, Earl Hubbell

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiao YangGrail, Inc, Menlo Park, CA, USA.
Yasushi SaitoGrail, Inc, Menlo Park, CA, USA.
Arjun RaoGrail, Inc, Menlo Park, CA, USA.
Hyunsung John KimGrail, Inc, Menlo Park, CA, USA.
Pranav SinghGrail, Inc, Menlo Park, CA, USA.
Eric ScottGrail, Inc, Menlo Park, CA, USA.
Matthew LarsonGrail, Inc, Menlo Park, CA, USA.
Wenying PanGrail, Inc, Menlo Park, CA, USA.
Mohini DesaiGrail, Inc, Menlo Park, CA, USA.
Earl HubbellGrail, Inc, Menlo Park, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

motivationCell-free nucleic acid (cfNA) sequencing data require improvements to existing fusion detection methods along multiple axes: high depth of sequencing, low allele fractions, short fragment lengths and specialized barcodes, such as unique molecular identifiers.

resultsAF4 was developed to address these challenges. It uses a novel alignment-free kmer-based method to detect candidate fusion fragments with high sensitivity and orders of magnitude faster than existing tools. Candidate fragments are then filtered using a max-cover criterion that significantly reduces spurious matches while retaining authentic fusion fragments. This efficient first stage reduces the data sufficiently that commonly used criteria can process the remaining information, or sophisticated filtering policies that may not scale to the raw reads can be used. AF4 provides both targeted and de novo fusion detection modes. We demonstrate both modes in benchmark simulated and real RNA-seq data as well as clinical and cell-line cfNA data. AVAILABILITY AND IMPLEMENTATION: AF4 is open sourced, licensed under Apache License 2.0, and is available at: https://github.com/grailbio/bio/tree/master/fusion.

Indexed as

SoftwareAllelesCell-Free Nucleic AcidsHigh-Throughput Nucleotide SequencingSequence Analysis, RNACell-Free Nucleic Acids

Identifiers

PMID31510681
PMCPMC6612805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.